Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05866003 · ClinicalTrials.gov registry record · NA
tDCS + CCFES-mediated Functional Task Practice for Post-stroke Upper Extremity Hemiplegia
A NA study of Stroke and Hemiplegia, sponsored by MetroHealth Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT05866003: Recruiting NA study of Stroke and Hemiplegia, sponsored by MetroHealth Medical Center.
NCT05866003 is a NA study of Stroke and Hemiplegia that is actively recruiting participants, run by MetroHealth Medical Center. The registered enrollment target is 63 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05866003, a NA study of Stroke and Hemiplegia, is actively recruiting participants, sponsored by MetroHealth Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
After a stroke, it is very common to lose the ability to open the affected hand. Occupational and physical rehabilitation therapy (OT and PT) combined with non-invasive brain stimulation may help a person recover hand movement. The purpose of this study is to compare 3 non-invasive brain stimulation protocols combined with therapy to see if they result in different amounts of recovery of hand movement after a stroke.
Primary Outcome
The BBT counts how many blocks a patient can pick up, move over a barrier, and release in 60 seconds.
Conditions Studied
Interventions
- DEVICE Active conventional tDCS montage plus CCFES
- DEVICE Active unconventional tDCS montage plus CCFES
- DEVICE Sham tDCS plus CCFES
- BEHAVIORAL CCFES with Occupational Therapy
Study Locations (1)
Ohio
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2028-04 |
| Phase | NA |
What NCT05866003 shows while recruiting
NCT05866003 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 4 interventions - of which Active conventional tDCS montage plus CCFES is the first listed.
NCT05866003 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05866003 about?
NCT05866003 is a clinical study titled "tDCS + CCFES-mediated Functional Task Practice for Post-stroke Upper Extremity Hemiplegia". After a stroke, it is very common to lose the ability to open the affected hand. Occupational and physical rehabilitation therapy (OT and PT) combined with non-invasive brain stimulation may help a person recover hand movement. The purpose of this study is to compare 3 non-invasive brain stimulatio...
What is the current status of trial NCT05866003?
This trial is currently recruiting. It is a NA study. The enrollment target is 63 participants. The study started on 2023-07-01. Estimated completion is 2028-04.
What conditions does trial NCT05866003 study?
This clinical trial studies the following conditions: Stroke, Hemiplegia, Upper Extremity Paresis.
What interventions are being tested in trial NCT05866003?
The interventions under investigation include: Active conventional tDCS montage plus CCFES (DEVICE), Active unconventional tDCS montage plus CCFES (DEVICE), Sham tDCS plus CCFES (DEVICE), CCFES with Occupational Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05866003?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05866003 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05866003's enrollment target sits among peer trials
63 201st of 454 higher than 252 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI